Search

everythinglearnresearchcommunity

for

Search:↓

Androgen use may increase the risk of stroke, but more research is needed.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

High levels of androgens during early development may cause PCOS-like symptoms.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Some supplements and hormones can increase hair loss by raising DHT levels.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Finasteride and metformin both help treat PCOS, but using them together works best.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Exercise and finasteride together improve ovary health in PCOS rats.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.